HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY TYPE 1
Clinical trials for HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY TYPE 1 trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single blood test speed up HAE diagnosis?
Diagnosis Recruiting nowThis study looks at whether measuring just one protein function (C1-inhibitor) can accurately diagnose hereditary angioedema (HAE), a rare condition causing sudden swelling. About 514 people in Algeria who are suspected of having HAE or have family members with it will take part.…
Matched conditions: HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY TYPE 1
Phase: NA • Sponsor: Takeda • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Real-World data: does takhzyro stop HAE swelling in saudi patients?
Knowledge-focused Recruiting nowThis study looks back at medical records of 50 people in Saudi Arabia with hereditary angioedema (HAE) who took Takhzyro (lanadelumab) to prevent attacks. Researchers want to see if the drug reduces HAE activity and improves quality of life after 6 to 12 months. No new treatments…
Matched conditions: HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY TYPE 1
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC